Oric Pharmaceuticals, Inc. (ORIC)
13.71
-0.14
(-1.01%)
USD |
NASDAQ |
Mar 06, 16:00
13.74
+0.04
(+0.26%)
After-Hours: 20:00
Oric Pharmaceuticals Cash from Investing (Quarterly) : 16.98M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Johnson & Johnson | -4.485B |
| Pfizer Inc. | -6.146B |
| Krystal Biotech, Inc. | 11.16M |
| Olema Pharmaceuticals, Inc. | 17.27M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -22.48M |
| Cash from Financing (Quarterly) | 1.50M |
| Free Cash Flow | -114.08M |
| Free Cash Flow Per Share (Quarterly) | -0.2214 |
| Free Cash Flow to Equity (Quarterly) | -26.85M |
| Free Cash Flow to Firm (Quarterly) | -22.71M |
| Free Cash Flow Yield | -9.49% |